Carrie Krehlik
Oficial de Recursos Humanos en Adicet Therapeutics, Inc. .
Perfil
Carrie Krehlik is currently the Chief Human Resource Officer & Senior VP at Adicet Therapeutics, Inc. She previously held the same position at Adicet Bio, Inc. from 2017 to 2021.
Prior to that, she was the Chief Human Resources Officer at Global Blood Therapeutics, Inc. from 2021 to 2022.
She also served as Vice President-Human Resources at InterMune, Inc. from 2012 to 2015 and at ZS Pharma, Inc. from 2015 to 2016.
Additionally, she was the Chief Human Resources Officer & Senior VP at resTORbio, Inc. She received an undergraduate degree from Miami University and an MBA from San Francisco State University.
Cargos activos de Carrie Krehlik
| Empresas | Cargo | Inicio |
|---|---|---|
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Oficial de Recursos Humanos | 01/11/2017 |
Antiguos cargos conocidos de Carrie Krehlik.
| Empresas | Cargo | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Oficial de Recursos Humanos | 01/12/2022 |
| ADICET BIO, INC. | Oficial de Recursos Humanos | 01/05/2021 |
| ZS PHARMA INC | Oficial de Recursos Humanos | 01/06/2016 |
| INTERMUNE INC | Oficial de Recursos Humanos | 01/03/2015 |
| ADICET BIO, INC. | Oficial de Recursos Humanos | - |
Formación de Carrie Krehlik.
| Miami University | Undergraduate Degree |
| San Francisco State University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ADICET BIO, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Carrie Krehlik
